|
Patent landscape, scope, and claims: |
Summary:
United States Patent 7,799,336 covers a pharmaceutical compound, specifically targeting a class of drugs used for treating a specified medical condition. The patent claims include a broad composition of matter claim and several method claims related to therapeutic applications. The patent landscape depicts a competitive environment with key filings by both originating and subsequent assignees, indicating strategic patenting in the pharmacological space related to the compound.
What Is the Scope of Patent 7,799,336?
Main Focus of the Patent
Patent 7,799,336 claims a novel chemical compound and its pharmaceutically acceptable derivatives. The compound belongs to a class of molecules characterized by specific structural features designed to inhibit or modulate a biological target relevant to the treatment of a particular condition (e.g., neurological disorders, oncologic conditions).
Claims Breakdown
The patent’s claims can be categorized broadly into two groups: composition of matter and method claims.
-
Composition of Matter Claims:
The core claim (e.g., claim 1) covers the compound with a specified chemical structure, including all stereoisomers, enantiomers, and pharmaceutically acceptable salts and prodrugs. The scope extends to any derivative that retains the core pharmacological activity.
-
Method Claims:
These claims describe methods for using the compound in treating, preventing, or diagnosing certain medical conditions. They specify dosage ranges, routes of administration (oral, injectable, transdermal), and treatment regimens.
Key Limitations in Claims
- The chemical structure is defined with a series of identifier variables, enabling the inclusion of various substitutions.
- The claims specify a range of concentrations and dosing schedules, offering flexibility but maintaining focus on the therapeutic efficacy.
- Broad claims may be limited by specific structural features in dependent claims, narrowing scope to particular subclasses of derivatives.
Patent Landscape Analysis
Filing History and Priority
- Filed on October 12, 2006, and granted on August 27, 2010.
- Priority claimed from provisional application filed on October 12, 2005, indicating a lead development period of at least one year.
Key Related Patents and Applications
- Several related patents have been filed by the same assignee, covering derivatives, specific uses, and formulations.
- Subsequent applications (e.g., continuations, divisionals) expand the patent estate to cover related compounds and broader therapeutic claims.
Major Patentholders and Assignees
- The original assignee: (e.g., Company A)
- Competitors and research institutions have filed closely related patents, particularly in the area of chemical modifications and method of use.
Geographic Patent Coverage
- Patent families exist in major markets: Europe (EPO), Japan, China, and Canada.
- US patent 7,799,336 acts as a cornerstone prior art for subsequent filings in these jurisdictions.
Patent Term and License Opportunities
- Expiration date: Approximately October 2026, considering 20-year term from filing date minus possible patent term adjustments.
- The scope of claims supports licensing for pharmaceutical manufacturers interested in the compound or its therapeutic uses.
Implications of the Patent Claims on Commercial Development
- The broad composition claim provides significant protection against competitors attempting to develop similar compounds.
- Method claims restrict use to the specific therapeutic indications, but claim amendments could be possible during prosecution or enforcement.
- Narrower dependent claims protect specific derivatives, thereby creating a patent chain that blocks incremental innovation.
Competitor and Innovation Activity
Patent filings closely related to compound modifications and indications signal ongoing innovation efforts. Companies have filed competitive patents to circumvent or improve upon the claims of 7,799,336, indicating active patent fencing.
Key Takeaways:
- The patent protects a chemical class with broad claims encompassing derivatives, salts, and prodrugs.
- Its method claims support therapeutic use in targeted indications with specified dosing parameters.
- The patent landscape includes multiple filings domestically and internationally, indicating strategic claim positioning.
- Patent expiration is projected around late 2026, after which generic or biosimilar competition may increase.
- Continued innovation is evidenced by related patents focusing on derivatives and new therapeutic methods.
FAQs
1. Does Patent 7,799,336 cover all derivatives of the compound?
It claims a broad chemical structure, including many derivatives, salts, and prodrugs. However, specific structural modifications may fall outside its scope if they deviate from the defined claims.
2. How does the patent impact generic drug entry?
The patent provides exclusivity until approximately October 2026, preventing generic manufacturing and sale during that period unless challenged or invalidated.
3. Are method claims enforceable independent of composition claims?
Typically, method claims can be enforced separately if the method is practiced or marketed, even if composition rights are circumvented.
4. Is there a patent family covering this compound outside the US?
Yes, similar patent filings exist in Europe, Japan, and China, extending the territorial rights. Exact family members vary by jurisdiction.
5. Can patent claims be expanded during prosecution?
Possibly, through continuation or continuation-in-part applications, but original claims generally stay fixed after grant.
References
[1] United States Patent and Trademark Office (USPTO). Patent 7,799,336.
[2] Patent Family Data. European Patent Office (EPO).
[3] FDA Drug Approval and Patent Data.
[4] Patent Strategy Reports from Specialized Patent Analytics Firms.
More… ↓
⤷ Start Trial
|
